Shorts Creep Back Into Amarin as Deal Speculation Quiets Down

(Bloomberg) -- Investors slowly raised bets against small-cap drugmaker Amarin Corp. as speculation around a possible deal has calmed in recent weeks. Shares have maintained their gains after the c...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.